baber/WOPTO huggingface dataset:
Patent ES-2096545-T1 (ES)
Title: Vehiculo utilitario que comprende un bastidor de cubierta en un telero movil.
Inventor: FRANZ CARL
IPC: B60J5/06
Filed: 1996-05-03
Abstract: VEHICULO UTILITARIO QUE TIENE UN BASTIDOR DE COBERTURA QUE LLEVA MONTANTES ANGULARES, TRAVIESAS LONGITUDINALES Y TRANSVERSALES SUSCEPTIBLES DE SER FIJADAS EN LOS EXTREMOS SUPERIORES DE LOS MONTANTES ANGULARES Y FORMANDO UN SOPORTE PARA UNA COBERTURA DE TECHO (16), ASI COMO AL MENOS UN TELERO (17) MONTADO MOVIL EN UN PRIMER MEDIO DE GUIA (93) DE AL MENOS UNA DE LAS TRAVIESAS (9), LLEVANDO ESTA TRAVIESA (9) UN SEGUNDO MEDIO DE GUIA (94) DESTINADO A RECIBIR, TAMBIEN EN FORMA DE MONTAJE MOVIL, CARROS (20) DE UN TOLDO (18) QUE CONSTITUYE UNA PARED LATERAL FLEXIBLE DEL VEHICULO, CARACTERIZADO POR QUE EL PRIMER MEDIO DE GUIA (93) ESTA DISPUESTO POR DEBAJO Y A UNA DISTANCIA VERTICAL DEL SEGUNDO MEDIO DE GUIA (94), CUBRIENDOSE AL MENOS PARCIALMENTE ESTE PRIMER Y ESTE SEGUNDO MEDIO DE GUIA DE MODO TRANSVERSAL.
Patent CY-1108089-T1 (CY)
Inventor: STAEBLER JEAN-LUC
IPC: E01F9/669
Filed: 2008-05-30
Abstract: The device has a vertical post (10) placed proximate to a road safety barrier formed by concrete walls (2, 2`), and an arm (13) mounted above the support and freely pivoted around a vertical axis (12). A part (13`) of the arm is made of plastic or light wood material. The arm is mounted pivotally around a horizontal axis (14) perpendicular to the direction of its length so as to pass from a horizontal position to a vertical position or to be inclined towards the height by pivoting around the horizontal axis. Independent claims are also included for the following: (1) a road beacon system, for shrinking or diverting a lane, including a set of road signaling devices (2) a method for deploying or folding a road signaling device.
Patent CY-1109681-T1 (CY)
Title: Υποκατεστημενα παραγωγα κιναζολινης ως αναστολεις των κινασων aurora
Inventor: JUNG FREDERIC HENRI
IPC: C07D401/14
Filed: 2009-12-17
Abstract: Η εφεύρεση παρέχει παράγωγα κιναζολίνης του τύπου (I): στην παρασκευή ενός φαρμάκου για χρήση στην αναστολή κινάσης Aurora και επίσης νέα παράγωγα κιναζολίνης, πορείες για την παρασκευή τους, φαρμακευτικές συνθέσεις που τα περιέχουν και την χρήση τους σε θεραπεία.
Patent CY-1110972-T1 (CY)
Inventor: HILL GEOFFREY R
IPC: A61P37/06
Filed: 2010-12-03
Abstract: The invention is directed to the use of cpn10 in transplantation and particularly to treatment and/or prevention of graft versus host disease. The invention provides a method of administration of cpn10 to a donor and/or recipient animal or cells, tissues or organs derived from the donor, although in a particularly advantageous form treatment of both the donor and recipient animal. The method may further include the administration to the donor and/or recipient animal at least one other immunosuppressive agent to prevent or alleviate graft versus host disease.
Patent CY-1111104-T1 (CY)
Title: Βελτιστοποιημενη dna και πρωτεϊνης αλληλουχια ενος αντισωματος για να βελτιωνεται η ποιοτητα και η αποδοση βακτηριακως εκφρασμενων πρωτεϊνων συντηξης αντισωματος
Inventor: WELS WINFRIED S
IPC: C12N15/62
Filed: 2011-01-13
Abstract: Το αντικείμενο της εφεύρεσης είναι μία βελτιστοποιημένη DNA αλληλουχία που κωδικοποιεί το scFv(FRP5) θραύσμα αντισώματος. Αυτή η νέα αλληλουχία αποτρέπει την δημιουργία του ανεπιθύμητου παρα-προϊόντος στην έννοια μιας scFv(FRP5)-ETA πρωτεΐνης σύντηξης και πιθανώς επίσης άλλων βακτηριακώς εκφρασμένων πρωτεϊνών σύντηξης που περιέχουν scFv(FRP5)s. Η DNA αλληλουχία του scFv(FRP5) πεδίου του scFv(FRP5)-ETA τροποποιήθηκε με εναλλαγή ενός διακριτού κωδικονίου, αποτρέποντας με τον τρόπο αυτό μία κατά τα άλλα πιθανή εσωτερική έναρξη μετάφρασης πρωτεΐνης.
Patent CY-1111565-T1 (CY)
Inventor: WEDGE STEPHEN ROBERT
IPC: A61P35/00
Filed: 2011-06-15
Abstract: The present invention relates to a method for the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human, which is optionally being treated with ionising radiation, particularly a method for the treatment of a cancer, particularly a cancer involving a solid tumour, which comprises: the administration of ZD6474 in combination with 5-FU; ZD6474 in combination with CPT-11; or ZD6474 in combination with 5-FU and CPT-11.
Patent CY-1117275-T1 (CY)
Title: Μεθοδοι θεραπευτικης αγωγης με τη χρηση συζευγματων αντισωματος enanti-erbb-μεϊτανσινοειδους
Inventor: ERICKSON SHARON
Filed: 2015-05-14
Abstract: Η αίτηση αφορά μεθόδους θεραπευτικής αγωγής με τη χρήση συζευγμάτων αντισώματος έναντι- ErbB-μεϊτανσινοειδούς και ειδών παραγωγής καταλλήλων για χρήση σε τέτοιες μεθόδους. Συγκεκριμένα, η εφεύρεση αφορά θεραπείες καρκίνου οι οποίες κατευθύνονται στον υποδοχέα ErbB με τη χρήση συζευγμάτων αντισώματος έναντι- ErbB-μεϊτανσινοειδούς.
Patent CY-1117583-T1 (CY)
Title: Στερεες μορφες περιλαμβανοντας ν-(5-τριτοταγες-βουτυλ-ισοξαζολ-3-υλ)-ν΄-{4-[7-(2-μορφολιν-4-υλ-αιθοξυ)ιμιδαζο[2,1-β][1,3]βενζοθειαζολ-2-υλ]φαινυλ}ουρια,συνθεσεις εξ΄ αυτης, και χρησεις μετ΄ αυτης
Inventor: BHAGWAT SHRIPAD
IPC: C07D513/04
Filed: 2016-05-24
Abstract: Στερεές μορφές περιλαμβάνοντας Ν-(5-τριτοταγές-βουτυλ-ισοξαζολ-3-υλ)-Ν'-{4-[7-(2-μορφολιν-4-υλ-αιθοξυ)ιμιδαζο[2,1-b][1,3]βενζοθειαζολ-2-υλ]φαινυλ}ουρία, συνθέσεις περιλαμβάνοντας τις στερεές μορφές, μέθοδοι παρασκευής των στερεών μορφών και μέθοδοι της χρήσης αυτών για την αγωγή διαφόρων παθήσεων και/ή διαταραχών αποκαλύπτονται.
Patent CY-1117812-T1 (CY)
Title: Χρηση πoλυστρωματiκoυ σωματιδιακου φιλτρου για τη μειωση της θολοτητας και του δεικτη sdi του νερου
Inventor: HOLMES NICOLAS
IPC: B01D21/00
Filed: 2016-07-15
Abstract: Η παρούσα εφεύρεση παρέχει τη χρήση συστήματος επεξεργασίας νερού που περιλαμβάνει κλίνη φίλτρων η οποία περιλαμβάνει στρώματα αδρανούς σωματιδιακού υλικού, έτσι ώστε, από το πάνω στρώμα προς το κάτω στρώμα, η τραχύτητα των σωματιδίων να μειώνεται ενώ η πυκνότητα του σωματιδιακού υλικού αυξάνεται, για τη μείωση τη θολότητας και/ή του δείκτη πυκνότητας ιλύος (SDI) του νερού.
Patent CY-1119193-T1 (CY)
Title: Διασπειρομενο δισκιο μισοπροστολης
Inventor: SELVARAJ SEKAR
IPC: A61K31/5575
Filed: 2017-08-08
Abstract: Η παρούσα εφεύρεση αναφέρεται σε ένα στερεό φαρμακευτικό σκεύασμα περιλαμβάνον μισοπροστόλη ή ένα φαρμακευτικώς αποδεκτό άλας αυτής. Συγκεκριμένα, η εφεύρεση αναφέρεται σε ένα διασπειρόμενο δισκίο περιλαμβάνον μισοπροστόλη ή ένα φαρμακευτικώς αποδεκτό άλας αυτής.
Patent CY-1121040-T1 (CY)
Title: Aντιικη θεραπεια
Inventor: UNDERWOOD MARK RICHARD
IPC: A61P31/18
Filed: 2018-10-23
Abstract: Η παρούσα εφεύρεση σχετίζεται με συνδυασμούς ενώσεων που περιέχουν αναστολείς ιντεγκράσης HIV κι άλλους θεραπευτικούς παράγοντες. Τέτοιοι συνδυασμοί είναι χρήσιμοι για την αναστολή της αντιγραφής του HIV, την πρόληψη και/ή τη θεραπεία μόλυνσης από HIV, και για τη θεραπεία του AIDS και/ή του ARC.
Patent CY-1123618-T1 (CY)
Title: Πολυπεπτιδια αντισωματα που ανταγωνιζονται cd40l
Inventor: NADLER STEVEN G
IPC: C07K16/28
Filed: 2020-02-18
Abstract: Παρέχονται πολυπεπτίδια αντισωμάτων που δεσμεύουν συγκεκριμένα ανθρώπινο CD40L. Τα πολυπεπτίδια αντισωμάτων δεν ενεργοποιούν αιμοπετάλια. Τα πολυπεπτίδια αντισωμάτων είναι χρήσιμα στην αγωγή παθήσεων που ενέχουν ενεργοποίηση CD40L, όπως είναι οι σχετικές με μοσχεύματα παθήσεις και οι αυτοάνοσες παθήσεις. Τα πολυπεπτίδια αντισωμάτων μπορεί να είναι αντισώματα επικρατειών που περιλαμβάνουν μία μονή επικράτεια VH ή VK. Η ημιπερίοδος-ζωής των πολυπεπτιδίων αντισωμάτων μπορεί να αυξηθεί από τροποποίηση των πολυπεπτιδίων αντισωμάτων για να είναι διπλά συγκεκριμένα αντιδραστήρια που μπορούν επίσης να δεσμεύσουν και ανθρώπινη λευκωματίνη ορού (ΗSA) ή ένα άλλο αντιγόνο.
Patent CY-1123947-T1 (CY)
Title: Βελτιστοποιημενος υποκινητης rpe65 και βελτιστοποιημενες κωδικοποιητικες αλληλουχιες
Inventor: SMITH ALEXANDER
IPC: C12N9/18
Filed: 2020-11-26
Abstract: Η παρούσα εφεύρεση σχετίζεται με την πρόληψη και/ή τη θεραπευτική αντιμετώπιση της δυστροφίας του αμφιβληστροειδούς σε ένα ασθενή, συμπεριλαμβανομένης της συγγενούς, αμαύρωσης του Leber.
Patent HR-P20090590-T1 (HR)
Title: Proteasome inhibitors and methods of using the same
Inventor: BERNAREGGI ALBERTO
IPC: A61K31/69
Filed: 2009-11-03
Abstract: The present invention provides boronic acid compounds, boronic esters, and compositions thereof that can modulate apoptosis such as by inhibition of proteasome activity. The compounds and compositions can be used in methods of inducing apoptosis and treating diseases such as cancer and other disorders associated directly of indirectly with proteasome activity.
Patent HR-P20100152-T1 (HR)
Title: Display for public use
Inventor: OGOREVC ANDRAZ
IPC: G09F27/00
Filed: 2010-03-17
Abstract: In a basic embodiment of a display for public use including a stand, an internal computer and an internal air conditioning system, the computer (10) is arranged according to the invention inside a housing (7) of the display, an evaporator (1) of an air conditioning device acting as an air delivering member is connected from below to an opening (18) in the floor panel of the housing (7) of the display, with said device being arranged inside the hollow stand (8) of the display, while a compressor (2) of the air conditioning device acting as a member for drawing in air is arranged on the floor panel of the stand (8). Modifications of said solution refer to standless displays providing the equipment either entirely in the housing of the display or entirely outside the housing of the display or partly inside partly outside.
Patent HR-P20120524-T1 (HR)
Title: Refractory composition for glass melting furnaces
Inventor: CHARLES W CONNORS
IPC: C04B35/48
Filed: 2012-06-21
Abstract: A refractory system includes a first set of components and a colloidal silica binder. The first set of components includes alumina and zirconia. The colloidal silica binder is at 5 wt % to 20 wt % of the dry weight of the first set of components. The refractory composition comprises 10 wt % to 45 wt % alumina, at least 35 wt % zirconia, and at least 20 wt % silica.
Patent SI-1200417-T1 (SI)
Title: Method for preparing 2-(2-arylmorpholin-2-yl)ethanol derivatives and intermediates
Inventor: AULOMBARD ALAIN
IPC: C07C45/56
Filed: 2000-07-07
Abstract: The invention relates to a process for the preparation of substituted 2-vinyl-2-arylmorpholine derivatives as described herein. This invention also relates to 2-vinyl-2-arylmorpholine derivatives as well as intermediates therefor.
Patent SI-1165010-T1 (SI)
Inventor: ANGELI ROBERTO
IPC: B67D7/70
Filed: 2000-03-14
Abstract: The present invention refers to a flask for liquids, for use in precision dispensers for liquids, which flask consists of a main body (1) provided with a threaded neck (8) equipped with means (81) for the press-block coupling of an attachment of a dispenser, in which the bottom of the flask consists of a pair of surfaces (9,91), which are inclined and which converge centrally into a cup (93) forming the lowest point of storage of the liquid in the flask (1). <IMAGE>
Patent SI-1499312-T1 (SI)
Title: The use of hydroxypyridone-derivatives in wound healing
Inventor: BOHN MANFRED
IPC: C07D213/89
Filed: 2003-04-08
Abstract: The present invention relates to the use of compounds of the formula I, <CHEM> in which R<1>; R<2>; R<3> and R<4> have the meanings indicated in the claims, for the treatment of wounds.
Patent SI-1462107-T1 (SI)
Title: Method of female contraception and kit for use in such method
Inventor: COELINGH BENNINK HERMAN JAN TIJMEN
IPC: A61K31/00
Filed: 2003-03-28
Abstract: The present invention is concerned with a method of contraception in a female mammal of childbearing capability, said method comprising orally administering to the female a combination of estrogen and progestogen continuously for at least 3 months, wherein the estrogen is selected from the group consisting of 17 beta -estradiol, precursors of 17 beta -estradiol and combinations thereof, said estrogen being administered in an amount equivalent to a daily oral dosage of 2.2-5 mg 17 beta -estradiol and said progestogen being administered in an amount equivalent to a daily oral dose of 5-50 mg dydrogesterone. <??>Another aspect of the invention relates to a kit comprising a plurality of oral dosage units, said plurality of daily hormone units containing an estrogen in an amount equivalent to 2.2-5 mg 17 beta -estradiol and a progestogen in an amount equivalent to 5-50 mg dydrogesterone, wherein the estrogen is selected from the group consisting of 17 beta -estradiol, precursors of 17 beta -estradiol and combinations thereof.
Patent SI-1767219-T1 (SI)
Title: Stable injectable diclofenac compositions
Inventor: PENKLER LAWRENCE JOHN
IPC: A61K47/00
Filed: 2004-11-30
Abstract: This invention relates to a stable parenteral aqueous solutions comprising either (a) diclofenac or a pharmaceutically acceptable diclofenac salt and a cyclodextrin, or (b) an inclusion complex of diclofenac or a pharmaceutically acceptable diclofenac salt and a cyclodextrin, or a mixture of (a) and (b), which are suitable for intramuscular and intravenous administration. The solutions contain diclofenac or diclofenac salt, cyclodextrin, and an antioxidant selected from monothioglycerol, or a combination of ethylene diamine tetra-acetic acid and N-acetyl-cysteine.
Patent SI-1637517-T1 (SI)
Title: 2-aminobicyclo 3.1.0 hexane-2,6-dicarboxylic ester derivative
Inventor: YASUHARA AKITO
IPC: A61P25/30
Filed: 2004-06-25
Abstract: A drug effective for the treatment and prevention of psychiatric disorders such as schizophrenia, anxiety and related ailments thereof, depression, bipolar disorder and epilepsy. The drug antagonizes the action of group II metabotropic glutamate receptors and shows high activity in oral administraiton  A 2-amino-bicyclo [3.1.0] hexane-2,6-dicarboxylic ester derivative represented by formula [I]   
[wherein R 1  and R 2  are identical or different, and each represents a hydrogen atom, a C 1-10 alkyl group or the like; X represents a hydrogen atom or a fluorine atom; Y represents -OCHR 3 R 4  or the like (wherein R 3  and R 4  are identical or different, and each represents a hydrogen atom, a C 1-10 alkyl group or the like; and n represents integer 1 or 2)], a pharmaceutically acceptable salt thereof or a hydrate thereof.
Patent SI-1748780-T1 (SI)
Title: Methods and related compositions for reduction of fat
Inventor: KOLODNEY MICHAEL S
IPC: A61K31/765
Filed: 2005-05-19
Abstract: Compositions and methods useful in the reduction of localized fat deposits in patients in need thereof using pharmacologically active detergents are disclosed. The pharmacologically active detergent compositions can additionally include antiinflammatory agents, analgesics, dispersion or anti-dispersion agents and pharmaceutically acceptable excipients. The pharmacologically active detergent compositions are useful for treating localized accumulations of fat including, for example, lower eyelid fat herniation, lipodystrophy grid fat deposits associated with cellulite and do not require surgical procedures such as liposuction.
Patent SI-1963516-T1 (SI)
Title: Method for the enantioselective enzymatic reduction of hydroxyketo compounds
Inventor: GUPTA ANTJE
IPC: C12P7/62
Filed: 2006-12-14
Abstract: In a process for the enantioselective enzymatic reduction of a hydroxy ketone of general formula I wherein R1═C1-C6 alkyl and R2═—Cl, —CN, —OH, —H or C1-C6 alkyl, into a chiral diol of general formula II wherein R1 and R2 have the same meaning as in formula I, the hydroxy ketone is reduced with an oxidoreductase in the presence of NADH or NADPH as a cofactor, wherein a) the hydroxy ketone is provided in the reaction at a concentration of ≧50 g/l, b) the oxidized cofactor NAD or NADP having formed is regenerated continuously by oxidation of a secondary alcohol of general formula RXRYCHOH, wherein RX, RY independently represent hydrogen, branched or unbranched C1-C8-alkyl and Ctotal≧3, and c) the reduction of the hydroxy ketone and the oxidation of the secondary alcohol are catalyzed by the same oxidoreductase.
Patent SI-2239906-T1 (SI)
Title: Apparatus for transmitting and receiving a signal and method of transmitting and receiving a signal
Inventor: KO WOO SUK
IPC: H04N19/89
Filed: 2008-12-11
Abstract: The invention relates to a method for transmitting a broadcasting signal, the method comprising: encoding physical layer pipe, PLP, data for conveying a service stream for forward encoding correction; mapping the encoded PLP data to symbols and time interleaving the mapped symbols; building a frame using the time-interleaved symbols ; modulating the frame by an orthogonal frequency divisional multiplexing scheme ;and transmitting a signal including the modulated frame and a first pilot, P1, symbol inserted to at a beginning part of the modulated frame, the P1 symbol having a structure including a first, second and third portions, wherein the second portion is an effective portion of the P1 symbol, the first portion carries frequency-shifted version of a first part of the second portion and the third portion carries frequency-shifted version of a second part of the second portion.  There is further disclosed an interrelated apparatus.
Patent DE-3587507-T2 (DE)
Inventor: LEWICKI JOHN
IPC: G01N33/92
Filed: 1985-10-16
Granted: 1993-11-18
Abstract: Monoclonal antibodies specific for a protein associated with a lung surfactant complex, decreased levels of which are related to respiratory distress syndrome, are disclosed. The antibodies are useful for prediction and diagnosis of respiratory problems in newborns.
Patent DE-3588076-T2 (DE)
Inventor: STOCKER BRUCE A D
IPC: C12N15/09
Filed: 1985-11-22
Granted: 1996-05-23
Abstract: Live vaccines are provided and methods for preparing the live vaccines for protection of a host from a pathogenic microorganism. The vaccines are prepared by introducing at least one modification in a gene involved in at least one, normally at least two, biosynthetic pathways, involving the production of products which are unlikely to be found in the disease susceptible host. The modification results in a gene change which cannot be repaired by a single step e.g. polynucleotide deletions and inversions. Where the aro gene suffers such a change, the resultant auxotrophic mutants require aromatic amino acids, p-aminobenzoic acid and 2, 3-dihydroxybenzoic acid or a highly concentrated source of absorbable iron. The auxotrophic mutations have substantially reduced or nonexistent virulence, while retaining the desired immunogenicity to initiate the immunogenic response. Various techniques can be employed for providing the desired change. Salmonella typhimurium strain SL1479 was deposited at the ATCC on September 7, 1982 and given ATGG Accession No. 39183; Salmonella dublin strain SL1438 was deposited on September 7, 1982 at the ATCC and given ATCC Accession No. 39184. Salmonella typhi strain 531Ty was deposited at the ATCC on November 21, 1984, and granted ATCC Accession No. 39926. This application is a continuation-in-part of U.S. Serial No. 675,381, filed November 27, 1984 which is a continuation-in-part of U.S. Serial No. 415,291, filed September 7, 1982 now U.S. Patent No. 4,550,081, issued October 29, 1985, which is a continuation-in-part of U.S. Serial No. 151,002, filed May 19, 1980, now abandoned, which disclosures are incorporated herein by reference.
Patent DE-3688073-T2 (DE)
Inventor: SCHLOTTER JUERGEN
IPC: G06F11/20
Filed: 1986-04-03
Granted: 1993-06-24
Abstract: Each car controller (10) in a multicar elevator system provides two serial asynchronous full duplex I/O channels to communicate with the next and previous car controllers. These two channels allow the transmission of a message in two opposite directions (32,34) on a communications ring. A single interruption of the ring, by a interrupted transmission line or a disturbed car controller for example, guarantees the transmission of messages to each car controller in at least one of the two directions. Each car controller contains three remote serial link interfaces. The first remote serial link interfaces to the car fixtures; car buttons, car tell tale lights, etc. The second remote serial link interfaces to car related hall fixtures; hall position indicator hall lantern, etc. The third remote serial link interfaces to the group related hall fixtures; hall buttons, hall tell tale lights, etc. To ensure the operation of the group related hall fixtures if a car controller fails or is switched off, a switchover module (28,36) is used. The purpose of the switchover module is to connect the group related hall fixtures to one of two car controllers. In the event that a car controller fails or is switched off, the switchover module connects the group related hall fixtures to the other car controller.
Patent DE-3751633-T2 (DE)
Inventor: RIRSCH ERIC DR
IPC: C04B111/27
Filed: 1987-10-02
Granted: 1996-07-11
Abstract: An uncured cementitious dough or paste, which is substantially free of particulate components having a diameter greater than 100 microns, said paste comprising in admixture;     a) At least one hydraulic cement; b) at least one polymer latex, the polymer being present in an amount of 1 to 20 parts by weight per 100 parts of the cement; c) total water in an amount from 8 to 20 parts by weight of water per 100 parts by weight of cement. A cured cementitious composition may be produced by heating said dough or paste at a temperature of above 100 DEG C and may be used for products such as roofing elements, for cladding the exterior walls of buildings and other building products.
Patent DE-3780259-T2 (DE)
Inventor: TAKEDA MIKIO
IPC: C07D417/04
Filed: 1987-11-13
Granted: 1992-12-24
Abstract: Disclosed are imidazolidinone compounds of general formula: <CHEM> wherein R represents a substituted or unsubstituted 5- or 6-membered nitrogen-containing heterocyclic monocyclic group; the ring A represents a substituted or unsubstituted phenyl group; Y represents vinylene group or ethynylene group; m represents 1 to 6; n represents 0, 1 or 2; and Q represents methylene group or a single bond, or a salt thereof, a process for preparing the same, a pharmaceutical composition comprising the same as an active ingredient, and the use of the same for the manufacture of a medicament for the treatment of depression or peptic ulcers, as an activator of cerebral metabolism, as an agent having a nootropic effect, or for use as a brain activator.
Patent DE-3787089-T2 (DE)
Inventor: HENRICSON KAJ
IPC: D21C9/18
Filed: 1987-12-15
Granted: 1994-01-05
Abstract: Removal of water from a fibre suspension, in particular cellulose pulp in a static thickner which essentially does not comprise moving parts. The clogging of the perforations in the screen sufaces (14,15,28,30,38,40,74,75,88,90) is reduced by dimensioning these perforations and the flow channels (13,33,37,76,87) in such a way that the pulp flows in the channels (13,33,37,76,87) as a plug flow, that is, the internal friction of the pulp is greater than the surface friction between the pulp and the screen surface (14,15,28,30,38,40,74,75,88,90). The process and apparatus (52,62) may be applied whenever a dilute pulp must be thickened, e.g. during pulp bleaching or refining of rejects.